Henrik Daver
1Patents
0h-index
5Co-inventors
19Inventor score
Filing activity: Sep 14, 2023 → Sep 14, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11958865B1 | Leucine-rich repeat kinase 2 (LRRK2) inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.